Global Medical Technologies (GMT Manila)

What Global Medical Technologies (GMT Manila) does

Global Medical Technologies (GMT Manila) is a Philippines-based medical distribution group founded in 2013 and headquartered in Quezon City. The company sources precision diagnostic tests from eight international partner laboratories in the US, Europe, South Korea, the UK, Australia, and Austria, and channels them to a referral network of 200-plus health practitioners spanning 15 medical specialties across the domestic market.

The company offers 45-plus diagnostic tests organized across six product categories, including microbiome analysis through its YourGutMap line, which incorporates AI-assisted interpretation. Its catalog spans specialty assays that would otherwise be inaccessible to Philippine clinicians, positioning GMT as a market-access intermediary rather than an in-house assay developer.

The business model combines one-time license revenue (per-test sales) with professional services revenue derived from practitioner consultations. Distribution is sales-led and practitioner-referred, with no consumer-facing app or API, no disclosed enterprise customers, and no public pricing. No funding rounds, leadership changes, or expansion into markets outside the Philippines have been disclosed over 13 years of operation.

Name

Global Medical Technologies (GMT Manila)

Legal name

Global Medical Technologies

Website

https://gmtmanila.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Global Medical Technologies distributes precision diagnostic tests from eight international laboratories to a network of 200-plus medical practitioners across 15 specialties in the Philippines, operating a one-time test-sale plus professional-services revenue model.

Ownership category

akta.pro rank

Product category

Precision Medicine Diagnostic Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK), Diagnostic & Laboratory Packaging (Specimen Containers, Transport Tubes) (IMALAIAF)

Keywords

• Precision diagnostic testing
• Medical distribution services
• Genetic testing services
• Microbiome analysis
• Pharmacogenetics testing

Headquarters

HQ city

Quezon City

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Diagnostic Test Services: GMT Manila distributes advanced medical diagnostic tests to health practitioners in the Philippines. Tests cover genetics, gut health, hormones, toxins, and metabolic markers. Revenue is generated through test kit sales and processing fees, with samples analyzed at partner laboratories in the US, Europe, and South Korea.
2. Consultation Services: Pre-test consultation services to guide practitioners and patients in selecting appropriate diagnostic tests. 10-minute consultation sessions are offered as part of the customer journey.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Global Medical Technologies (GMT Manila) is a Philippine medical distribution group that brings internationally approved advanced diagnostic technologies to Filipino patients and health practitioners. The company distributes a portfolio of precision medicine tests spanning genetics, gut microbiome, hormones, toxins, allergies, and metabolic markers. Samples are collected locally and shipped to eight world-leading international partner laboratories in the US, Europe, UK, Austria, Australia, and South Korea for analysis.

Product overview

Global Medical Technologies (GMT Manila) is a medical distribution group that provides precision medicine diagnostic testing services to Filipino patients and healthcare practitioners. The company does not offer a unified software platform but rather distributes a portfolio of advanced diagnostic tests organized across six health categories: (1) Gut & Immune Health including Food Sensitivity Test, GI360, Comprehensive Stool Analysis with Parasitology, YourGutMap Microbiome, ALEX3 Allergy Test, Tryptase Test, and Celiac & Gluten Sensitivity; (2) Nutrient & Metabolic Markers including Organic Acids Test, CardioMetabolic Profile, Metabolism Sensor, Vitamin D, Fatty Acids, and Amino Acids; (3) DNA & Genetics for Psychiatry, Oncology, and Gene Expression including BRCANext, CancerNext, DNA Methylation, Genomind Mental Health Map, Genomind PGx, HapOnco® tests, and OncoStrands™ tests; (4) DNA & Genetics for Medical and Lifestyle including 13 sensor tests (Beauty, Biological Age, Burnout, Depression, Diabetes, Epigenetic, Hypertension, Nutrition, Performance, Pharmaco, Premium Plus, and Shape Sensors); (5) Neuro-Hormone Markers including Comprehensive Hormone Profile, Comprehensive Plus Profile, Comprehensive Neurotransmitter Profile, HuMap, and Melatonin Profile; and (6) Toxin Markers including TOXDetect Profile, MycoTOX Profile, Glyphosate Test, Hair Elements, RBC Elements, and Whole Blood Elements. Samples are collected locally in the Philippines and sent to GMT's eight international partner laboratories (Cambridge Nutritional Sciences, Novogenia, Mosaic Diagnostics, Genomind, Doctor's Data Inc., Gutmapdx, LifeStrands Genomics, and GC Labs) for analysis. Results are delivered as comprehensive precision-mapped reports.

Differentiator

Problem solved

Functional benefit

Products and services

• Gut & Immune Health Tests

Quantifiable outcome

• Network of over 200 practitioners across 15 medical specialties
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core.

• Cambridge Nutritional Sciences (CNS)coreTechnology or IntegrationCambridge Nutritional Sciences (Cambridgeshire, UK) specializes in the detection of immune reactions to food, often described as food sensitivity, which is linked to health conditions including skin issues, migraine, brain fog, weight gain, and bloating.
• NovogeniacoreTechnology or IntegrationNovogenia (Eugendorf, Austria) provides preventive and lifestyle genetic diagnostic testing services in the areas of cardiology, nutrition, gynecology, andrology, and pharmacology.
• Mosaic DiagnosticscoreTechnology or IntegrationMosaic Diagnostics (Kansas, USA) is a world leader in providing testing for metabolic, mitochondrial, nutritional and environmental factors in chronic illnesses. Helps medical practitioners provide patients with the most personalized medicine possible.
• GenomindcoreTechnology or IntegrationGenomind (Pennsylvania, USA) is an award-winning company comprised of pioneering scientists and thought leaders in brain health and genetics. The company aims to help clinicians optimize treatment decisions for patients with neuropsychiatric medical conditions.
• Doctor's Data, Inc.coreTechnology or IntegrationDoctor's Data, Inc. (Illinois, USA) has provided innovative specialty testing to healthcare practitioners around the world from their advanced, CLIA licensed and CAP-accredited laboratory since 1972. They specialize in tests for essential and toxic elements, nutritional deficiencies, gastrointestinal function, cardiovascular risk, and metabolic abnormalities.
• GutMapDxcoreTechnology or IntegrationGutMapDx (York, UK) specializes in personalized nutrition for gut health. Their tests allow health practitioners to unlock key health insights, with test reports that are easy to understand, interpret, and implement.
• LifeStrands GenomicscoreTechnology or IntegrationLifeStrands Genomics (Victoria, Australia) revolutionizes personalized healthcare towards a patient-centric approach by providing more accurate and clinically relevant cancer tests with better accessibility. LifeStrands Genomics, HaploX, and Ambry Genetics comprise GMT's precision oncology solutions.
• GC LabscoreTechnology or IntegrationGC Labs (Gyeonggi-do, South Korea) is South Korea's premier clinical and anatomic pathology reference laboratory, offering a comprehensive portfolio of over 5,000 clinical assays. As the first laboratory in Korea to achieve CAP accreditation, they utilize total laboratory automation to deliver high-speed, precision diagnostics to over 5,000 medical institutions worldwide.

Scale indicators4 records

Recent moves4 records

Expansion highlights2 records

Direct peers

• Genomind: US-based pharmacogenetics testing company and one of GMT Manila's core lab partners (PGx for 125 psychiatric medications). Directly comparable because it sells the same flagship PGx assay that GMT Manila distributes in the Philippines, and could plausibly expand direct into Southeast Asia.
• Mosaic Diagnostics: US specialty lab focused on metabolic, mitochondrial, nutritional, and environmental testing for chronic illness — and a GMT Manila partner. Directly comparable because it offers overlapping specialty diagnostics (Organic Acids Test, toxic elements) through similar practitioner-distribution channels.
• Doctor's Data, Inc. CLIA-licensed, CAP-accredited specialty lab operating since 1972 providing toxic elements, nutritional, GI, and cardiovascular testing. Comparable as both a GMT Manila partner and a competing specialty diagnostics provider serving functional medicine practitioners globally.

Broad incumbents

• Natera: Large US-based genetic testing company with strong positions in reproductive health, oncology, and organ transplantation. Comparable as a precision genetic testing incumbent whose Signatera MRD and tumor profiling assays overlap with GMT Manila's HapOnco MRD and OncoStrands offerings.
• Quest Diagnostics: One of the two largest US clinical laboratory companies with extensive specialty and esoteric testing menus. Comparable as a broad incumbent whose advanced diagnostics portfolio overlaps with GMT Manila's PGx, cancer genetics, and metabolic panels, and which could plausibly enter the Philippines directly.
• Eurofins Genomics: International laboratory services group with deep presence in Europe and Asia. Comparable as a global specialty diagnostics incumbent that could compete with GMT Manila's international lab partners for the Philippine market, and which already serves a similar B2B practitioner channel globally.
• Myriad Genetics: US-based genetic testing company with established hereditary cancer (BRACAnalysis) and pharmacogenomics products. Comparable because its portfolio overlaps with GMT Manila's BRCANext/CancerNext and Pharmaco Sensor offerings, and represents a potential competitor in oncology genetics distribution.

Regional players

• Prenetics: Hong Kong-headquartered genetic and infectious disease testing company with operations across Southeast Asia. Comparable as a regional precision medicine player in adjacent Asia-Pacific markets, providing a benchmark for what a scaled Asia-focused diagnostics distribution platform looks like.

Emerging players

• Nalagenetics: Singapore-based pharmacogenetics testing company focused on Southeast Asia. Comparable because it operates in the same PGx category as GMT Manila's Genomind offering and targets similar Southeast Asian patient populations, representing a potential regional peer in the psychiatric/PGx niche.
• Color Health: US-based genetic testing platform offering hereditary cancer, pharmacogenomics, and whole-genome screening through a population-scale model. Comparable as a genetic testing platform competing for the same clinical-grade precision medicine demand that GMT Manila serves in the Philippines.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/gmtmanila
• Instagraminstagram.com/gmtmanilainc
• LinkedInlinkedin.com/company/global-medical-technologies-manila-inc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Medical Technologies (GMT Manila)